Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. 37% in the last one. View the latest SPDR S&P Biotech ETF (XBI) stock price and news, and other vital information for better exchange traded fund investing. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. Brazil. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. NEW: Experience our best charts yet. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. XBI has a beta of 0. XBI. The XBI broke out in Q3 2016 and again in June 2017. 26 during this last 52. 19%. 75. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. XBI is suitable for investors seeking to. 79 in February 2021 and has fallen over (50%) to $76. Implied XBI Analyst Target Price: $135. News & World Report, XBI. The beaten-down prices offer a solid buying opportunity for investors. According to data from U. 9%: Israel: 3. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 01 to $0. 66% so far this year and in the past. 57 billion. 28% so far this year and in the past one. Holdings. Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. A few losers won't cause XBI to crash. 52%. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. -listed equities in the biotechnology sector. Holdings. NBI IBBQ XBI BTK FBT IBB Other Topics Indexes Stocks ETFs Coronavirus Prableen Bajpai Prableen Bajpai is the founder of FinFix Research and. Growth of Hypothetical $10,000. Dollar Tree Inc. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). 64 billion, a PE ratio of 11. Its holdings reflect the movement of like 750b worth of companies. Thu, Nov 9, 1:16 PM ET, Market News Video. It has a total of 153 holdings. 94 per share, with $107. Currency in USD Follow 2W 10W 9M 72. 7% vs -5. 5% on the day. This table shows the interest rate that must be paid by a short seller of US:XBI to the lender of that security. If Moderna's share price. London. XBI currently has 133 holdings. Both BBC and XBI are ETFs. The fund's investments total to approximately $6. 2 %. 75M), Brown Advisory. Neena Mishra May 10, 2023. 9% vs -5. Looking at the chart above, XBI's low point in its 52 week range is $72. Meanwhile, XBI equal weights its holdings. In addition to holding 155 positions, its top 10 holdings make up just 14. 61%) At close: 04:00PM EST Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. 80 per share, with $92. The Direxion Daily Cloud Computing Bull 2X Shares seek daily investment results, before fees and expenses, of 200% of the performance of the Indxx USA Cloud Computing Index. 50 -0. MTD. 78% of XBI's total assets under management. XBI has traded between. Analyst Forecast. 07. 60 as the 52 week high point — that compares with a last trade of $69. Looking at the chart above, XBI's low point in its 52 week range is $62. 10 as of November 2, 2022. 1. Mirati. 87. " The 12-month stock price forecast is $22. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Looking at the chart above, XBI's low point in its 52 week range is $61. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 80% of total assets under management. 67. Discover historical prices for XBI stock on Yahoo Finance. 1% vs 0. 42 billion worth of. Visitors trend 2W 10W 9M. large-cap stocks. Snapshot for the SPDR S&P BIOTECH ETF ETF (XBI), including recent quote, performance, objective, analyst opinions, and commentary. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. 12% in the last one year (as of 03/16/2023). In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. 66738-1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. The sale of ETFs is subject to an activity assessment fee (from $0. 1. com. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. But that definitely wasn't the case recently. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. 8% of its total assets under management. Performance and Risk So far this year, XBI has added roughly 1. SPDR S&P Biotech ETF Stock Up 1. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. 22% of total assets) As of November 16, 2023. XBI ETF's holdings offer significant diversification. $0. 6% of the fund. 7. Looking at the chart above, XBI's low point in its 52 week range is $115. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). 03 per $1,000 of principal). 45% and is down about -9. Looking at the chart above, XBI's low point in its 52 week range is $72. AU. Company specialized in: Holding Companies. 50. 10% of. Chart. XBI is an almost pure play on the biotechnology sector. •. Summary. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. 58%). It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. argenx SE ADR. There is no overlap of the top 10 holdings between SBIO and XBI. RGLD. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. 26 during this last 52-week period. 5. In addition to holding 155 positions, its top 10 holdings make up just 14. 97. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. Monday's ETF Movers: XBI, QCLN. S. Find exchange traded funds (ETFs) whose sector aligns with the same commodity grouping as the symbol you are viewing. Asset type. VHT has a higher 5-year return than XBI (7. by Sweta Killa Published on September 18,2023. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). $0. 79 as the 52 week high point — that compares with a last trade of $133. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 77. XBI: SPDR S&P Biotech ETF - Fund Holdings. Fidelity does not endorse or adopt their content. In its most recent earnings release, President and Chief Executive Officer Christopher A. XBI is suitable for investors seeking to. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. VEEV. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. The company has an 88. 2B Total Assets 0. 2 %. Holdings Details. XBI has lost 27. Holdings. Looking at the chart above, XBI's low point in its 52 week range is $100. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. Region Percentage; North, Central and South America: 99. IMVT. 64 per share, with $174. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Currently, the. 50. 52 (-1. Its top 10 holdings account for approximately 16. 1% over the past year to close the last trading session at $81. SBIO holds 79 companies vs. It's trading down (17%) versus LABU, down (68%) in one-year performance. Single Cell Genomics Workflow Automation Cell Analytics Lab Equipment Spatial Genomics Lab Equipment. The gross expense ratio is the fund’s total annual operating expenses ratio. XBI has an overall POWR Rating of D, equating to a Sell. The table below compares many ETF metrics between IBB and XBI. Overview. 60 as the 52 week high point — that compares with a last trade of $69. The following charts reflect the geographic spread of WCLD's underlying holdings. Performance. 18% and is down about -39. com) ReturnsXBI's top 10 holdings account for about 10. 78% of XBI's total assets under management. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. Only one of these, AbbVie, is a. In addition, the recent spike in volatility has increased option prices even. XBI Holdings5 Beaten-Down ETFs to Buy Now. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. GrowthStrategy: Traditional growth investing is an investment. Staples:. m. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. XBI has a higher expense ratio than XLV (0. With XBI trading at a recent price near $131. 7. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. 250-391-1110. Oct 10, 2022 01:14PM EDT. Assets Under Management. Feel free to the browse the list and view the comparisons that are of an interest to you. 35% for XBI, but SBIO yields 2. Top 10 Holdings (14. View and export this data back to 2006. Written by BNK Invest for BNK Invest ->. Name Symbol % Assets. Below is the comparison between BBC and XBI. Summary. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Sector Exposure and Top Holdings. 1005 Broad St 5 Victoria BC V8W 2A1. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. Across the 192 current stocks in the fund, all holdings have a weighting between 0. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 98 and standard deviation of 40. Currency in USD. com. XBI has traded between $62. 0. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. 02%. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. 35%). BBC vs XBI. Fund size is a good indication of how many other investors trust this fund. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. 17% for the trailing three-year period, which makes XBI a high. 06 as the 52 week high point — that compares with a last trade of $109. 10(-0. Net Expense Ratio. 78% of XBI's total assets under management. Advertisement. US. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. View Holdings As of 09/30/2023. Both VHT and XBI are ETFs. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . 32% of the total portfolio assets. 51. Immunovant Inc. Performance and Risk The ETF has lost about -29. 1% vs 0. The top holding in XBI receives just a 1. 38%. Nov 20, 2023Top 10 Holdings. ETF Channel Staff - Friday, October 20, 6:48 AM. Both ARKG and XBI are ETFs. Performance and Risk The ETF has lost about -29. XBI holdings. Dividend Yield. 96 on December 31, 2021, to $83 per share at the end of 2022. 12% in the last one year (as. Again, top 10 holdings. Twin City Holdings Ltd from Port Alberni, BC. Wix. The sale of ETFs is subject to an activity assessment fee (from $0. 97% in the last one year (as of 11/07/2022). 16. 08 per unit, that means that analysts see 59. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. XBI has traded between $64. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. View the latest ETF prices and news for better ETF investing. Figure 1 - XBI ETF top 10 holdings (ssga. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. With about 135 holdings, it effectively. 70% so far this year and is down about -16. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. The ETF has lost about -22. While this ETF allocates. $6. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 67% Top 10 holdings are 16. A few losers won't cause XBI to crash. 26% rating in the component of Value. BIIB is also in the top 15 XBI holdings. Holdings; Performance; Risk; Advertisement. Better trading starts here. The top 10 holdings account for about 10. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. It has a total of 153 holdings. 86% so far this year and is down about -32. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 36% of total assets under management. Diversification. The top 10 holdings account for about 14. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The split for XBI took place on September 11, 2015. The iShares Core S&P 500 ETF Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 94 per share, with $121. 15 billion assets under management. Expense ratio and liquidity are average for the group. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). Of course the mega caps are less volatile in general for any sector. 84 Billion in assets under management, while XBI has 4. 86 Prior Close 70. Top 10 Holdings (16. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. The famed investor's Berkshire Hathaway (. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. 1% over the past year to close the last trading session at $81. Aug 4, 2021 10:47AM EDT. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). Below is the comparison between BBH and XBI. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. In contrast, most. 40 for Nov. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. -listed equities in the biotechnology sector. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Holdings AS OF 04/30/2023. XBI has an overall POWR Rating of D, equating to a Sell. Themes & Subsectors ETFs. Free ratings, analyses, holdings, benchmarks, quotes, and news. 01%). Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. Below is the comparison between VHT and XBI. NAV as of Nov 16, 2023. IBB outperformed the S&P 500 last year and did much better than XBI. 35% ; Sectors:. WIX. Health Care Fund Highlights: 137 Total Holdings $5. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Again, top 10 holdings. Below is the comparison between BBH and XBI. Looking at the chart above, XBI's low point in its 52 week range is $97. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 56% vs 0. 3. Also includes news, ETF details and other investing information. 69% allocation. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. N/A. While IBB has many more holdings than XBI (376 vs. 95. 35%. Top 10 Holdings (14. View complete XBI exchange traded fund holdings for better informed ETF trading. Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. 44 per share, with $92. 91 Billion . Seeking AlphaXBI vs. Holdings. Index Dividend Yield The weighted average of the underlyings’ indicated annual dividend A high-level overview of SPDR® S&P Biotech ETF (XBI) stock. 18. 16bn USD. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Share class size. Summary From a population of some 350 actively-traded, substantial, and growing ETFs this is a currently attractive addition to a portfolio whose principal objective is wealth accumulation by active investing. 47 million over the past three months. LABU has a lower 5-year return than XBI (-46. Additionally. 264,458,476. As of 09/30/2023. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. Quote. underlying holdings of the fund. Holdings. Performance and Risk. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio.